Patterson-UTI Energy, Inc. (PTEN) Q4 2025 Earnings Call Transcript
Patterson-UTI (PTEN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.12 per share a year ago.
Patterson-UTI (PTEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Patterson-UTI (PTEN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Patterson-UTI (PTEN) reported earnings 30 days ago. What's next for the stock?
The headline numbers for Patterson-UTI (PTEN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Patterson-UTI (PTEN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to break-even earnings per share a year ago.
Patterson-UTI (PTEN) reported earnings 30 days ago. What's next for the stock?
While the top- and bottom-line numbers for Patterson-UTI (PTEN) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Patterson-UTI Energy, Inc. (NASDAQ:PTEN ) Q2 2025 Earnings Conference Call July 24, 2025 10:00 AM ET Company Participants C. Andrew Smith - Executive VP & CFO Michael James Sabella - Vice President of Investor Relations William Andrew Hendricks - President, CEO & Director Conference Call Participants Atidrip Modak - Goldman Sachs Group, Inc., Research Division Connor Patrick Jensen - Raymond James & Associates, Inc., Research Division Daniel Robert Kutz - Morgan Stanley, Research Division Derek John Podhaizer - Piper Sandler & Co., Research Division Douglas Lee Becker - Capital One Securities, Inc., Research Division Grant Hynes - JPMorgan Chase & Co, Research Division Jeffrey Michael LeBlanc - Tudor, Pickering, Holt & Co. Securities, LLC, Research Division John Matthew Daniel - Daniel Energy Partners, LLC Keith MacKey - RBC Capital Markets, Research Division Saurabh Pant - BofA Securities, Research Division Scott Andrew Gruber - Citigroup Inc., Research Division Stephen David Gengaro - Stifel, Nicolaus & Company, Incorporated, Research Division Sungeun Kim - Barclays Bank PLC, Research Division Operator Hello, and thank you for standing by.
Patterson-UTI (PTEN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.05 per share a year ago.